Psilocybin and chronic neuropathic pain: a systematic review
Regional Anesthesia & Pain Medicine August 5, 2024 Harman Chopra, Shravani Durbhakula, Alexander Shustorovich et al. 8 citations
A systematic review of 28 studies on psilocybin for chronic pain management found that most evidence is low or very low quality (76.2% of studies). Several moderate-to-low-quality studies used a 0.14 mg/kg dosing protocol. The results suggest promise for psilocybin in relieving chronic pain, but methodological weaknesses and a lack of high-quality evidence highlight the need for further research with standardized protocols.